(RTTNews) - Appili Therapeutics (APLIF) revealed Loss for second quarter of -C$0.99 million
The company's bottom line came in at -C$0.99 million, or -C$0.01 per share. This compares with -C$0.74 million, or -C$0.01 per share, last year.
The company's revenue for the period rose 1900% to C$0.10 million from C$0.005 million last year.
Appili Therapeutics earnings at a glance (GAAP) :
-Earnings: -C$0.99 Mln. vs. -C$0.74 Mln. last year. -EPS: -C$0.01 vs. -C$0.01 last year. -Revenue: C$0.10 Mln vs. C$0.005 Mln last year.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
